BioCentury
ARTICLE | Company News

Astellas, Tolmar sales and marketing update

January 24, 2011 8:00 AM UTC

Tolmar granted Astellas' Astellas Pharma Europe Ltd. subsidiary marketing rights to Eligard leuprolide acetate in China, Taiwan, Thailand, Hong Kong, the Philippines, Indonesia, the Middle East, North Africa and Commonwealth of Independent States to treat prostate cancer. Further terms were not disclosed. ...